Showing results (381-390 of 453) with videos related to
Sort By:
Pageof 46
International Immunopharmacology|February 21, 2024
Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human studyYoung-Min Ye, Jung-Won Park, Sae-Hoon Kim, et al.Allergy|November 24, 2019
Macrophage-derived progranulin promotes allergen-induced airway inflammationJun-Pyo Choi, So Young Park, Keun-Ai Moon, et al.Allergy, Asthma & Immunology Research|July 2, 2021
COVID-19 Vaccine-associated Anaphylaxis and Allergic Reactions: Consensus Statements of the KAAACI Urticaria/Angioedema/Anaphylaxis Working GroupMi Ae Kim, Yong Won Lee, So Ri Kim, et al.Allergy, Asthma & Immunology Research|July 9, 2011
Vancomycin-associated spontaneous cutaneous adverse drug reactionsSo-Yeon An, Eui-Kyung Hwang, Joo-Hee Kim, et al.Pharmacoepidemiology and Drug Safety|June 25, 2010
Current status of Oriental medicine in treating Korean allergy patientsYoo Seob Shin, Jung-Won Park, Yong-Won Lee, et al.Allergy, Asthma & Immunology Research|September 16, 2017
Clinical Characteristics of Exacerbation-Prone Adult Asthmatics Identified by Cluster AnalysisMi Ae Kim, Seung Woo Shin, Jong Sook Park, et al.The Korean Journal of Internal Medicine|July 8, 2021
Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthmaJae-Woo Jung, Hae-Sim Park, Choon-Sik Park, et al.The Journal of Allergy and Clinical Immunology. in Practice|August 9, 2025
Efficacy and Safety of Tezepelumab in Adults With Severe, Uncontrolled Asthma in Asia: Results From the Phase 3 DIRECTION StudyXinyan Yang, Lihong Wang, Kewu Huang, et al.The Journal of Allergy and Clinical Immunology|August 16, 2011
A synonymous variation in protease-activated receptor-2 is associated with atopy in Korean childrenJi Hyun Lee, Kyung Won Kim, Heon Yung Gee, et al.Journal of Asthma and Allergy|December 28, 2020
Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung FunctionIan D Pavord, Salman Siddiqui, Alberto Papi, et al.Pageof 46